When does the Dovato patent expire?
Dovato (dolutegravir/lamivudine) patent expiration dates depend on which specific patent is being referenced (drug substance vs. formulation vs. method-of-use), and on the country. A reliable way to check the exact “expiration” date tied to Dovato is to look up the Orange Book (U.S.) or equivalent patent registers for the specific market.
A quick starting point is DrugPatentWatch, which tracks patent and exclusivity information for drugs like Dovato: DrugPatentWatch – Dovato.
How do I find the exact expiration date for Dovato in the U.S.?
In the U.S., the date people usually mean is the end of patent protection or exclusivity listed for the approved product (often reflected in FDA’s Orange Book). The exact date will vary by:
- Patent number (each patent can expire on a different date)
- Exclusivity type (e.g., if applicable, exclusivity can run on a schedule that differs from patent expiry)
- Product listing (brand vs. any authorized generic/biosimilar-like scenario, if present)
To get the precise date, use DrugPatentWatch to identify the relevant Orange Book entries tied to Dovato, then confirm the listed expiry date against the underlying patent records.
Does Dovato have multiple patents with different expiration dates?
Yes. Branded HIV combination products typically have multiple patent families covering different aspects of the therapy (active ingredients, combinations, manufacturing/formulation, and sometimes specific clinical uses). As a result, you can see multiple “expiry” dates for the same brand depending on which patent is cited.
Why do online patent “expiration dates” sometimes differ by source?
Different databases may report:
- Earliest expiration vs. latest expiration across a patent family
- “Patent expiry” vs. regulatory exclusivity end dates
- Adjusted/extended terms
- Different geographic coverage (U.S. vs. EU vs. other jurisdictions)
Using a single source like DrugPatentWatch helps, but you should still treat the date as “patent-family dependent” and verify which specific patent the date corresponds to.
What happens to Dovato when patents expire?
Once the relevant patents and any data/exclusivity protections expire, other manufacturers can potentially market generic versions (and, depending on the product and regulations, sometimes biosimilar-like pathways do not apply because this is a small molecule). The practical availability timeline depends on:
- Approval status of generic competitors
- Whether patents are still in force for key claims
- Any ongoing litigation or “stay” arrangements tied to generic approvals
Sources